While the technology for developing artificial intelligence-powered chatbots has existed for some time, a new viewpoint piece in JAMA lays out the clinical, ethical, and legal aspects that must be considered before applying them in healthcare. And while the emergence of COVID-19 and the social distancing that accompanies it has prompted more health systems to…
NEW YORK, NY (July 24, 2020) — The number of heart transplants in the United States declined sharply during the beginning of the pandemic, even in areas of the country with few COVID-19 cases at the time, according to an analysis by researchers at Columbia University Irving Medical Center. The study found that the number…
WASHINGTON, July 24, 2020 — Journalists may now apply for press credentials for the American Chemical Society (ACS) Fall 2020 Virtual Meeting & Expo, one of the largest scientific conferences of the year. The meeting will be held online Aug. 17-20, 2020. Thousands of scientists and other attendees are expected to gather for more than…
Boston, MA — Early and accurate detection is critical for preventing the spread of COVID-19 and providing appropriate care for patients. Nasopharyngeal (NP) swabs, which require inserting a long shaft into the nasal cavity to collect a sample from the back of the nose and throat, are currently the gold standard for collecting a specimen…
A new study of human olfactory cells has revealed that viral invasion of supportive cells in the nasal cavity might be driving the loss of smell seen in some patients with COVID-19. The findings show that non-neuronal cells in the brain and nose express genes critical for SARS-CoV-2 entry, while neurons do not; therefore, non-neuronal…
At a glance: Loss of smell is the main neurological symptom of COVID-19, but the underlying mechanism has been unclear New study shows infection of nonneuronal supporting cells in the nose and forebrain may be responsible for loss of smell in patients with COVID-19 Findings suggest olfactory sensory neurons are not vulnerable to SARS-CoV-2…
A new study found raised levels of transforming growth factor beta-induced protein (TGFBIp) in blood sampled from roughly 100 people hospitalized for COVID-19, and further found that elevated levels of both the normal and acetylated forms of TGFBIp correlated with the severity of disease symptoms in these patients. While more work will be required to…
In Perinatal Cardiology, fetal cardiology experts provide key information on tools for fetal evaluation through echocardiography / cardiac ultrasonography, with a primary focus on the nature and prenatal detection of structural and functional cardiac heart defects (CHDs). This two-part book will enlighten the readers with details about different types of fetal cardiac abnormalities along with…
Current observations suggest that the coronavirus SARS-CoV-2 causes severe symptoms mainly in elderly patients with chronic disease. However when two pairs of previously healthy young brothers from two families required mechanical ventilation at the intensive care unit in rapid succession, doctors and researchers at Radboud University Medical Center were inclined to consider that genetic factors…
Today’s Food and Drug Administration (FDA) approval of the first CAR T-cell therapy for mantle cell lymphoma (MCL) represents a key advance for patients with relapsed or treatment-resistant forms of the disease, say Dana-Farber Cancer Institute investigators who helped conduct the decisive clinical trial of the therapy. Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) will be…